Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04441229 · ClinicalTrials.gov registry record · NA
Mobile Attentional Bias Modification Training in Pediatric MS
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 37
- Enrollment target
NCT04441229 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 37 participants.
The verdict
NCT04441229, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
Study Summary
This study will examine the feasibility of using a mobile ABMT application as a treatment modality in the Pediatric Multiple Sclerosis population. Participants will be asked to undergo one hour-long baseline evaluation, followed by at-home ABMT application sessions. Subjects will complete online REDCap or MyCap surveys weekly and at the end of the study.
Interventions
- BEHAVIORAL ABMT mobile application
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2020-06-12 |
| Est. Completion | 2021-03-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04441229
The ClinicalTrials.gov registry entry for NCT04441229 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ABMT mobile application is the first listed.
NCT04441229 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04441229 about?
NCT04441229 is a clinical study titled "Mobile Attentional Bias Modification Training in Pediatric MS". This study will examine the feasibility of using a mobile ABMT application as a treatment modality in the Pediatric Multiple Sclerosis population. Participants will be asked to undergo one hour-long baseline evaluation, followed by at-home ABMT application sessions. Subjects will complete online RED...
What is the current status of trial NCT04441229?
This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2020-06-12. Estimated completion is 2021-03-26.
What interventions are being tested in trial NCT04441229?
The interventions under investigation include: ABMT mobile application (BEHAVIORAL).
Who is sponsoring clinical trial NCT04441229?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.